Literature DB >> 8012513

Aspartate aminotransferase-linked immunoglobulin complexes in serum of a patient with primary biliary cirrhosis.

Y Matsuda1, Y Amuro, T Hada, K Higashino, N Ueki, M Fujikura, A Tonomura, T Yamamoto, K Yamaguchi, S Shimomura.   

Abstract

A 51-year-old woman who had been treated for primary biliary cirrhosis (PBC) was admitted to our hospital for evaluation of unexplained, isolated, persistently increased aspartate aminotransferase (AST) activity. Results of laboratory tests on admission showed: AST 171 KU, alanine aminotransferase 28 KU, and anti-mitochondrial titer 1/1280. Results of hepatitis B surface antigen (HBs Ag) and hepatitis C virus antibody (HCV Ab; C100-3) assays were negative. Histology of a liver biopsy specimen was compatible with a diagnosis of PBC (stage III of Scheuer's classification). The molecular size of serum AST was estimated to be more than 500,000 by high-performance size-exclusion liquid chromatography. Electrophoretic analysis showed an abnormal band of AST between supernatant AST (sAST) and mitochondrial AST (mAST), which band was characteristic of AST-immunoglobulin complexes (AST-Ig). Ouchterlony double-diffusion and immunoprecipitation tests identified the immunoglobulin component as IgM. The presence of AST-Ig appeared to be responsible for the elevated serum AST.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012513     DOI: 10.1007/bf02358687

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  10 in total

1.  Incidence and properties of aspartate aminotransferase-immunoglobulin complexes in patients with a high serum aspartate to alanine aminotransferase ratio.

Authors:  T Moriyama; M Nobuoka; M Makino
Journal:  Clin Chim Acta       Date:  1990-09       Impact factor: 3.786

2.  Mitochondrial aspartate aminotransferase linked to immunoglobulin G of the kappa-lambda type: report of a case.

Authors:  T Moriyama; T Ashiie; K Kikuiri; Y Nishiyama; Y Ito; M Nobuoka; M Makino
Journal:  Clin Chim Acta       Date:  1986-11-15       Impact factor: 3.786

Review 3.  Electrophoretic analysis of enzyme-linked immunoglobulins and their clinical significance.

Authors:  T Tozawa
Journal:  J Chromatogr       Date:  1991-09-13

4.  Innocent elevation of aspartate aminotransferase.

Authors:  M S Connelly; H J Kennedy; C M Dawson; G D Howe; T R Tickner
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

5.  Enzyme-linked immunoglobulins and their clinical significance.

Authors:  T Tozawa
Journal:  Electrophoresis       Date:  1989 Aug-Sep       Impact factor: 3.535

6.  Proteolytic measurement of mitochondrial aspartate aminotransferase in human serum.

Authors:  Y Watazu; H Okabe; H Sugiuchi; Y Uji; Y Shirahase; N Kaneda
Journal:  Clin Biochem       Date:  1990-04       Impact factor: 3.281

7.  A new cause of increased serum aspartate aminotransferase activity.

Authors:  A Konttinen; J Murros; K Ojala; M Salaspuro; H Somer; J Räsänen
Journal:  Clin Chim Acta       Date:  1978-03-01       Impact factor: 3.786

8.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

9.  Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis.

Authors:  U Sundin
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

10.  Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.

Authors:  A L Williams; J H Hoofnagle
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

  10 in total
  2 in total

1.  Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.

Authors:  Hengyi Gao; Feng Zhu; Min Wang; Hang Zhang; Dawei Ye; Jiayin Yang; Li Jiang; Chang Liu; Renyi Qin; Lunan Yan; Guangqin Xiao
Journal:  Oncotarget       Date:  2017-01-17

2.  Distribution of serum concentrations reported for macroenzyme aspartate aminotransferase (macro-AST).

Authors:  Asa S Rubin; David A Sass; Douglas F Stickle
Journal:  Pract Lab Med       Date:  2017-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.